WEISS, ROBERTA,KEMPENI, JOACHIM,FISCHKOFF, STEVEN A
申请号：
NZ59687802
公开号：
NZ596878A
申请日:
2002.06.05
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
596878 METHODS OF ADMINISTERING ANTI-TNFALPHA ANTIBODIES Provided is the use of an isolated human anti-TNF antibody, or an antigen-binding portion thereof, in the manufacture of a medicament for treating keloid formation in a human subject, wherein the medicament is adapted for biweekly, subcutaneous administration as a 40 mg dose, and wherein the human anti-TNF antibody, or antigen-binding portion has defined sequences of CDRs with specified mutations.
